alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS FOR THE ELEVENTH CIRCUIT

________________________ No. 14

- 13532 Non

- Argument Calendar

________________________ D.C. Docket No. 8:14

- cv - 01398

- EAK Bankruptcy No. 8:13

- bk

- 16027

- CPM
In Re: JUDITH L. HACKBART, Debtor.

______________________________________________________ BANK OF AMERICA, N.A., Plaintiff

- Appellant,

versus JUDITH L. HACKBART, Defendant

- Appellee.

________________________ Appeal from the United States District Court for the Middle District of Florida

________________________ (December 15, 2014) Case: 14-13532 Date Filed: 12/15/2014 Page: 1 of 22 Before ROSENBAUM, JILL PRYOR, and COX, Circuit Judges. PER CURIAM: Appellee Judith Hackbart is a Chapter 7 debtor

. Hackbart has two mortgages on her house. The first mortg age exceeds the current market value of the house. Appellant Bank of America, N.A. holds the second mortgage. Hackbart filed a motion to void, or “strip off,” the junior lien under § 506(d) of the Bankruptcy Code. The bankruptcy court granted the motion , and the district court affirmed. We affirm the district court’s order. Folendore v. Small Bus. Admin. , 862 F.2d 1537 , 1540 (11th Cir. 1989); McNeal v. GMAC Mortgage, LLC , 735 F.3d 1263 , 1265

– 66 (11th Cir. 2012)

. Should Bank of America choose to petition this Court for en banc consideration of the iss ue it raises here, this panel is of the opinion that the Court should seriously consider the petition. AFFIRMED. Case: 14-13532 Date Filed: 12/15/2014 Page: 2 of 2
**Exhibit 32.2**

 

**CERTIFICATION PURSUANT TO**

**18            U.S.C. SECTION 1350,**

**AS            ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Annual Report of Pacific Alliance Corporation            (the “Company”) on Form 10-KSB for the year ended December 31, 2007 as            filed with the Securities and Exchange Commission on the date hereof (the            “Report”), I, David Knudson, Secretary/Treasurer and Principal Financial            Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted            pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my            knowledge:

 

(1) the Report fully complies with the requirements of Section            13(a) or 15(d)of the Securities Exchange Act of 1934; and

 

(2) the information contained in the Report fairly presents, in all            material respects, the financial condition and results of operations of the            Company.

 

Dated:  April 11, 2008

 

/s/ David Knudson

 

David Knudson

Secretary/Treasurer/Principal Financial Officer
[Federal Register Volume 66, Number 247 (Wednesday, December 26, 2001)]
[Notices]
[Pages 66418-66423]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-31576]



[[Page 66418]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Cooperative Arrangement Between the United States Departments of 
Health and Human Services and Agriculture and the Secretariats of 
Health and Agriculture, Livestock, Rural Development, Fish, and Food of 
the United Mexican States Regarding Cooperative Activities to Enhance 
the Safety of Food for Human Consumption

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is providing notice of 
a cooperative arrangement between the Department of Health and Human 
Services and the Department of Agriculture of the United States of 
America and the Secretariat of Health and the Secretariat of 
Agriculture, Livestock, Rural Development, Fish, and Food of the United 
Mexican States. The purpose of this arrangement is to strengthen 
existing scientific and public health protection cooperative activities 
related to the regulation of the safety of food to achieve a reduction 
in the incidence of foodborne illnesses in both countries.

DATES:  The arrangement became effective September 4, 2001.

FOR FURTHER INFORMATION CONTACT: Camille Brewer, International 
Activities Coordinator for Food, Center for Food Safety and Applied 
Nutrition (HFS-032), Food and Drug Administration, 200 C St. SW., 
Washington, DC 20204, 202-260-2314. (After December 14, 2001, the 
Center for Food Safety and Applied Nutrition's address will be 5100 
Paint Branch Pkwy., College Park, MD 20740.)

SUPPLEMENTARY INFORMATION: This cooperative arrangement is being 
published in accordance with 21 CFR 20.108(c) which states that all 
written agreements and memoranda of understanding between FDA and 
others shall be published in the Federal Register.

    Dated: December 13, 2001.
Margaret M. Dotzel,
Associate Commissioner for Policy.
    The arrangement is set forth in its entirety as follows:
BILLING CODE 4160-01-S

[[Page 66419]]

[GRAPHIC] [TIFF OMITTED] TN26DE01.153


[[Page 66420]]


[GRAPHIC] [TIFF OMITTED] TN26DE01.154


[[Page 66421]]


[GRAPHIC] [TIFF OMITTED] TN26DE01.155


[[Page 66422]]


[GRAPHIC] [TIFF OMITTED] TN26DE01.156


[[Page 66423]]


[GRAPHIC] [TIFF OMITTED] TN26DE01.157

[FR Doc. 01-31576 Filed 12-21-01; 8:45 am]
BILLING CODE 4160-01-C
{"agency":"FMCS","generated":"2015-04-24 11:12:56","items":[{"id":"1","parent":null,"text":"Reporting Quarter","due":null,"due_date":"2012\/10\/15","fields":[{"type":"select","name":"2-1-year","label":"Reporting Year","options":[{"label":"2011","value":"2011"},{"label":"2012","value":"2012"},{"label":"2013","value":"2013"},{"label":"2014","value":"2014"},{"label":"2015","value":"2015"}],"value":"2015"},{"type":"select","name":"2-1-quarter","label":"Reporting Quarter","options":[{"label":"Q1","value":"Q1"},{"label":"Q2","value":"Q2"},{"label":"Q3","value":"Q3"},{"label":"Q4","value":"Q4"}],"value":"Q2"}],"multiple":false},{"id":"1-1","parent":"1","text":"Ten Oldest Requests","due":null,"due_date":"2012\/10\/15","fields":[{"type":"select","name":"2-1-1-oldest","label":"Ten Oldest","options":[{"label":"0","value":"0"},{"label":"1","value":"1"},{"label":"2","value":"2"},{"label":"3","value":"3"},{"label":"4","value":"4"},{"label":"5","value":"5"},{"label":"6","value":"6"},{"label":"7","value":"7"},{"label":"8","value":"8"},{"label":"9","value":"9"},{"label":"10","value":"10"}],"value":"6"}],"multiple":false},{"id":"1-3","parent":"1","text":"","due":null,"due_date":"2012\/10\/15","fields":[{"type":"select","name":"2-1-3-closed","label":"Ten Oldest Closed","options":[{"label":"0","value":"0"},{"label":"1","value":"1"},{"label":"2","value":"2"},{"label":"3","value":"3"},{"label":"4","value":"4"},{"label":"5","value":"5"},{"label":"6","value":"6"},{"label":"7","value":"7"},{"label":"8","value":"8"},{"label":"9","value":"9"},{"label":"10","value":"10"}],"value":"4"}],"multiple":false},{"id":"1-2","parent":"1","text":"FOIA Requests Information","due":null,"due_date":"2012\/08\/21","fields":[{"type":"text","name":"2-1-2-component","label":"Component","options":[],"value":["FMCS"]},{"type":"text","name":"2-1-2-received","label":"Received","options":[],"value":["15"]},{"type":"text","name":"2-1-2-processed","label":"Processed","options":[],"value":["14"]},{"type":"text","name":"2-1-2-backlog","label":"Backlog","options":[],"value":["2"]}],"multiple":true}],"year":"2015","quarter":"Q2"}
#### UNITED STATES of America, Plaintiff-Appellee, v. Dwayne ANDERSON, a/k/a Dewayne Anderson, Defendant-Appellant.

No. 09-4809.

United States Court of Appeals, Fourth Circuit.

Submitted Oct. 22, 2010.

Decided Dec. 6, 2010.

*815John J. Pizzuti, McCamic, Sacco, Pizzuti & McCoid, PLLC, Wheeling, West Virginia, for Appellant. Betsy C. Jividen, Acting United States Attorney, Zelda E. Wesley, Assistant United States Attorney, Clarksburg, West Virginia, for Appellee.

Before WILKINSON, SHEDD, and DAVIS, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Dwayne Anderson was sentenced to 292 months’ imprisonment after a jury found him guilty of conspiracy to possess with intent to distribute and distribute in excess of fifty grams of cocaine base, in violation of 21 U.S.C. §§ 841, 846 (2006) (Count One), and distribution of 1.73 grams of cocaine and aiding and abetting, in violation of 21 U.S.C. § 841(a)(1) and 18 U.S.C. § 2 (2006) (Count Thirteen). Anderson filed a timely appeal, challenging the sufficiency of the evidence supporting the convictions. In our prior decision, we concluded that sufficient evidence supported Anderson’s conviction on Count Thirteen, but not as to Count One. We affirmed Anderson’s conviction on Count Thirteen, reversed his conviction on Count One, and remanded. *United States v. Anderson,*282 Fed.Appx. 255 (4th Cir.2008).

On remand, the district court adopted its findings from the earlier sentencing proceeding regarding Anderson’s relevant conduct and criminal history and sentenced Anderson to 188 months’ imprisonment. Anderson again appeals, contending that the district court made numerous errors in his resentencing — including failing to order a new Presentence Report and using acquitted conduct in determining his relevant conduct — and abused its discretion by denying his recusal motion.

We have thoroughly examined the record and find Anderson’s contentions to be without merit. Accordingly, we affirm his sentence. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of BF Acquisition Group IV,
Inc. (the "Company") on Form 10-QSB for the period ending January 31, 2004 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, William Colucci, President of the Company, certify, pursuant to 18
U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

         (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: June 16, 2004

                                 /s/ William Colucci
                                 ------------------------------
                                 William Colucci, President
                                 BF Acquisition Group III, Inc.
EXHIBIT 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(CHIEF EXECUTIVE OFFICER)



In connection with the Quarterly
Report of SourcingLink.net, Inc. (the Company) on Form 10-QSB for the period ended September 30, 2003 (the Report), I, Marcel van Heesewijk, Chairman, Chief Executive Officer and Vice President of Sales of the Company,
certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:



|(1) |  | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and
|--- |  | -----------------------------------------------------------------------------------------------------------------------------------------------



|(2) |  | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------



Dated: November 13, 2003



/s/ Marcel van HeesewijkMarcel van HeesewijkChairman, Chief Executive Officer and Vice President of Sales
### IN THE COURT OF APPEALS OF THE STATE OF WASHINGTON DIVISION ONE

STATE OF WASHINGTON

, Respondent

,

v.

TED JENSEN

, Appellant

. No. 84377

- 0

- I

DIVISION ONE

UNPUBLISHED OPINION

PER CURIAM. Ted Jensen appeals a t rial court order denying his “Motion for

Order to Show Cause re: Vacation of Judgment/Order” and his “Motion for Relief from

Judgment Revoking Deferred Sentence.” His court

- appointed attorney has filed a

motion to withdraw on the ground that there is no b asis for a good faith argument on

review. Pursuant to State v. Theobald , 78 Wn.2d 184, 470 P.2d 188 (1970), and

Anders v. California , 386 U.S. 738, 87 S. Ct. 1396, 18 L. Ed. 2d 493 (1967), the motion

to withdraw must:

[1] be accompanied by a brief referri ng to anything in the record that might arguably support the appeal. [2] A copy of counsel’s brief should be furnished the indigent and [3] time allowed him to raise any points that he chooses; [4] the court

— not counsel

— then proceeds, after a full examinat ion of all the proceedings, to decide whether the case is wholly frivolous.

Theobald , 78 Wn.2d at 185 (quoting Anders , 386 U.S. at 744) (alterations in original).

This procedure has been followed. Jensen’s counsel on appeal filed a brief with

the motion to withdraw. Jensen was served with a copy of the brief, and informed of hisNo. 84377

- 0

- I / 2

- 2

- right to file a statement of additional grounds for review. Jensen filed a statement of

additional grounds.

The material facts are accurately set forth in counsel’s brief in support of the

motion to withdraw. The court has reviewed the briefs filed in this court and has

independently reviewed the entire record. The court specifically considered the

following potential issues raised by counsel: whether the trial court erred b y denying his

motions to vacate his judgment and sentence on his conviction for theft in the second

degree and whether Jensen received ineffective assistance of appointed counsel. The

court also considered the following issues raised by Jensen: whether th e record is

insufficient to permit review because it did not contain verbatim reports of proceedings

from 1984 and 1986, and whether the prosecutor committed misconduct in obtaining a

continuance of the hearing on his motions.

The issues raised by counsel and by Jensen are wholly frivolous. The motion to

withdraw is granted and the appeal is dismissed.

FOR THE COURT:
**Exhibit 32**

 

**Certificationby Chief Executive Officer of Quarterly Report**

 

 

CERTIFICATIONOF QUARTERLY REPORT

 

I, Robert K. Lifton, Chairman and Chief ExecutiveOfficer of Medis Technologies Ltd. (the “Company”), certify, pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

 

(1) the Quarterly Report on Form 10-Q of theCompany for the quarterly period ended June 30, 2003 (the “Report”) fullycomplies with the requirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

 

(2) the information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 
| Dated:  August 6, 2003 |
|-----------------------------|
|                        |
|                        | /s/ ROBERT K. LIFTON |   |
|                        | Robert K. Lifton |
|                        | Chairman and Chief Executive  Officer |

 

 

**Certificationby Chief Financial Officer of Quarterly Report**

 

 

CERTIFICATIONOF QUARTERLY REPORT

 

I, Israel Fisher, Chief Financial Officer ofMedis Technologies Ltd. (the “Company”), certify, pursuant to Section 906 ofthe Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

 

(1) the Quarterly Report on Form 10-Q of theCompany for the quarterly period ended June 30, 2003 (the “Report”) fullycomplies with the requirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

 

(2) the information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 
| Dated:  August 6, 2003 |
|-----------------------------|
|                        |
|                        | /s/ ISRAEL FISHER |   |
|                        | Israel Fisher |
|                        | Chief Financial Officer |

 

----
EXHIBIT
32.1





CERTIFICATION
OF


PRINCIPAL
EXECUTIVE OFFICER


AND
PRINCIPAL FINANCIAL OFFICER


PURSUANT
TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





I, Louis C. Drapeau, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that the Annual Report of InSite Vision Incorporated
on Form 10-K for the annual period ended December 31, 2008 fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended and that information contained in such Annual Report of InSite
Vision Incorporated on Form 10-K fairly presents, in all material respects, the
financial condition and results of operations of InSite Vision
Incorporated.





By:
                    /s/Louis C. DrapeauName:
                    Louis
      C. DrapeauTitle:
                    Interim
      Chief Executive Officer(Principal
      Executive Officer)Chief
      Financial Officer(Principal
      Financial Officer)Date:
                    March
      13, 2009
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED JUNE 16, 2023

NO. 03-23-00211-CR

Travis Jarella Foy, Appellant

v.

The State of Texas, Appellee

APPEAL FROM THE 264TH DISTRICT COURT OF BELL COUNTY

BEFORE JUSTICES BAKER, KELLY, AND SMITH

DISMISSED FOR WANT OF JURISDICTION-- OPINION BY JUSTICE KELLY

This is an appeal from the judgment of conviction entered by the trial court. Having reviewed 

the record, it appears that the Court lacks jurisdiction over this appeal. Therefore, the Court 

dismisses the appeal for want of jurisdiction. Because appellant is indigent and unable to pay 

costs, no adjudication of costs is made.
Exhibit 32.1

CERTIFICATION OF

PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Louis Drapeau, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that the Annual Report of InSite Vision Incorporated on Form 10-K/A for the annual period ended December 31, 2009 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and
that information contained in such Annual Report of InSite Vision Incorporated on Form 10-K/A fairly presents, in all material respects, the financial condition and results of operations of InSite Vision Incorporated.



By:

/s/ Louis DrapeauName:

Louis DrapeauTitle:

Interim Chief Executive Officer(Principal Executive Officer)Chief Financial Officer(Principal Financial Officer)Date:

April 30, 2010
Amendment to the Amended & Restated Employee Stock



 Exhibit 4.1.2 
 OSCIENT PHARMACEUTICALS CORPORATION 
 AMENDED AND RESTATED 
 EMPLOYEE STOCK PURCHASE PLAN 
 AMENDMENT 
 Pursuant to Section 17 of the Oscient Pharmaceuticals Corporation Amended and Restated Employee Stock
Purchase Plan (the “Plan”), Oscient Pharmaceuticals Corporation hereby amends the Plan, subject to stockholder approval, as follows: 
 1. Section 2 of the Plan is amended, effective as of the date hereof, by deleting the first sentence thereof and replacing said sentence in its entirety as follows: 
 “Under the Plan, there is available an aggregate of not more than 431,250 shares of Stock (subject to adjustment as provided in
Section 15) for sale pursuant to the exercise of options (“Options”) granted under the Plan to employees of the Company (“Employees”) who meet the eligibility requirements set forth in Section 3 hereof (“Eligible
Employees”).” 
 2. Section 7 of the Plan is amended, effective as of the date hereof, by deleting the first
sentence thereof and replacing said sentence in its entirety as follows: 
 “The Purchase Price of Stock issued pursuant
to the exercise of an Option will be 95% of the fair market value of the Stock at (a) the time of grant of the Option or (b) the time at which the Option is deemed exercised, whichever is less.” 
 IN WITNESS WHEREOF, Oscient Pharmaceuticals Corporation has caused this Amendment to be executed by its duly authorized officer this 8th day of March,
2007. 
  

			
	OSCIENT PHARMACEUTICALS CORPORATION
		
	By:	 	/s/ PHILIPPE M. MAITRE
	Name:	 	Philippe M. Maitre
	Title:	 	Senior Vice President
and Chief Financial Officer
EXHIBIT 23

CONSENT OF ARTHUR ANDERSEN LLP

As independent public accountants, we hereby consent to the
incorporation by reference in this Form 10-K, of our report
dated March 14, 2002 included in Registration Statements
on Form S-8 File No 33-30991, File No. 33-52622, File
No. 33-60101 and File No. 33-60101 and File No. 333-18601
and on Form S-3 File No. 33-44869 and File No. 333-18599. It
should be noted that we have not audited any financial statements
of the Company subsequent to December 31, 2001 or performed and
audit procedures subsequent to the date of our report.



/s/  Arthur Andersen LLP
------------------------
Arthur Andersen LLP



Los Angeles, California
March 28, 2002
{"version":"1.0","provider_name":"Federal Mediation and Conciliation Service","provider_url":"https:\/\/www.fmcs.gov","title":"Site Map - Federal Mediation and Conciliation Service","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"LbmKQgI1Dh\"><a href=\"https:\/\/www.fmcs.gov\/site-map\/\">Site Map<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.fmcs.gov\/site-map\/embed\/#?secret=LbmKQgI1Dh\" width=\"600\" height=\"338\" title=\"“Site Map” — Federal Mediation and Conciliation Service\" data-secret=\"LbmKQgI1Dh\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n"}